Abraldes JG - Search Results

1

Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.

Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Brujats A, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J; PreDesCI Study Investigators. Villanueva C, et al. Among authors: abraldes jg. J Hepatol. 2021 Sep;75(3):589-599. doi: 10.1016/j.jhep.2021.04.022. Epub 2021 Apr 24. J Hepatol. 2021. PMID: 33905794 Clinical Trial.

2

Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.

Bañares R, Moitinho E, Matilla A, García-Pagán JC, Lampreave JL, Piera C, Abraldes JG, De Diego A, Albillos A, Bosch J. Bañares R, et al. Among authors: abraldes jg. Hepatology. 2002 Dec;36(6):1367-73. doi: 10.1053/jhep.2002.36947. Hepatology. 2002. PMID: 12447861 Clinical Trial.

3

Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt.

Bellis L, Moitinho E, Abraldes JG, Graupera M, García-Pagán JC, Rodés J, Bosch J. Bellis L, et al. Among authors: abraldes jg. Gut. 2003 Jan;52(1):130-3. doi: 10.1136/gut.52.1.130. Gut. 2003. PMID: 12477774 Free PMC article.

4

Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.

Graupera M, García-Pagán JC, Abraldes JG, Peralta C, Bragulat M, Corominola H, Bosch J, Rodés J. Graupera M, et al. Among authors: abraldes jg. Hepatology. 2003 Jan;37(1):172-81. doi: 10.1053/jhep.2003.50004. Hepatology. 2003. PMID: 12500202

5

Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.

Bellis L, Berzigotti A, Abraldes JG, Moitinho E, García-Pagán JC, Bosch J, Rodés J. Bellis L, et al. Among authors: abraldes jg. Hepatology. 2003 Feb;37(2):378-84. doi: 10.1053/jhep.2003.50053. Hepatology. 2003. PMID: 12540788 Clinical Trial.

6

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodés J, Bosch J. Abraldes JG, et al. Hepatology. 2003 Apr;37(4):902-8. doi: 10.1053/jhep.2003.50133. Hepatology. 2003. PMID: 12668985

7

Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers.

Graupera M, García-Pagán JC, Parés M, Abraldes JG, Roselló J, Bosch J, Rodés J. Graupera M, et al. Among authors: abraldes jg. J Hepatol. 2003 Oct;39(4):515-21. doi: 10.1016/s0168-8278(03)00347-7. J Hepatol. 2003. PMID: 12971960

8

Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.

Morales J, Moitinho E, Abraldes JG, Fernández M, Bosch J. Morales J, et al. Among authors: abraldes jg. Hepatology. 2003 Dec;38(6):1378-83. doi: 10.1016/j.hep.2003.09.023. Hepatology. 2003. PMID: 14647048

9

Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera.

Alvarez-Larrán A, García-Pagán JC, Abraldes JG, Arellano E, Reverter JC, Bosch J, Cervantes F. Alvarez-Larrán A, et al. Among authors: abraldes jg. Br J Haematol. 2004 Feb;124(3):329-35. doi: 10.1046/j.1365-2141.2003.04770.x. Br J Haematol. 2004. PMID: 14717780 Free article.

10

Management of gastrointestinal bleeding in patients with cirrhosis of the liver.

Bosch J, Abraldes JG. Bosch J, et al. Among authors: abraldes jg. Semin Hematol. 2004 Jan;41(1 Suppl 1):8-12. doi: 10.1053/j.seminhematol.2003.11.003. Semin Hematol. 2004. PMID: 14872414 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters